Diuron-induced rat urinary bladder carcinogenesis: Mode of action and human relevance evaluations using the International Programme on Chemical Safety framework

2014 ◽  
Vol 44 (5) ◽  
pp. 393-406 ◽  
Author(s):  
Mitscheli Sanches Da Rocha ◽  
Lora L. Arnold ◽  
Maria Luiza Cotrim Sartor De Oliveira ◽  
Shadia M. Ihlaseh Catalano ◽  
Ana Paula Ferragut Cardoso ◽  
...  
2008 ◽  
Vol 7 (3) ◽  
pp. 211
Author(s):  
B. Parada ◽  
A. Figueiredo ◽  
F. Reis ◽  
P. Nunes ◽  
P. Eufrásio ◽  
...  

1998 ◽  
Vol 89 (1) ◽  
pp. 22-26 ◽  
Author(s):  
Eijiro Okajima ◽  
Masahiro Tsutsumi ◽  
Seiichiro Ozono ◽  
Hiroyuki Akai ◽  
Ayumi Denda ◽  
...  

1998 ◽  
Vol 160 (5) ◽  
pp. 1930-1931
Author(s):  
E. Okajima ◽  
M. Tsutsumi ◽  
S. Ozono ◽  
H. Akai ◽  
A. Denda ◽  
...  

1989 ◽  
Vol 141 (6) ◽  
pp. 1454-1457 ◽  
Author(s):  
Yukio Homma ◽  
Tadao Kakizoe ◽  
Shoji Samma ◽  
Ryoichi Oyasu

1993 ◽  
Vol 14 (11) ◽  
pp. 2277-2281 ◽  
Author(s):  
Tatsuyuki Otoshi ◽  
Hiroyuki Iwata ◽  
Shinji Yamamoto ◽  
Takashi Murai ◽  
Shuji Yamaguchi ◽  
...  

1989 ◽  
Vol 10 (11) ◽  
pp. 2081-2087 ◽  
Author(s):  
Peggy Campbell ◽  
Charles C. Irving ◽  
Ronald Lindahl

PPAR Research ◽  
2008 ◽  
Vol 2008 ◽  
pp. 1-14 ◽  
Author(s):  
Martin B. Oleksiewicz ◽  
Jennifer Southgate ◽  
Lars Iversen ◽  
Frederikke L. Egerod

Despite clinical promise, dual-acting activators of PPARαandγ(here termed PPARα+γagonists) have experienced high attrition rates in preclinical and early clinical development, due to toxicity. In some cases, discontinuation was due to carcinogenic effect in the rat urothelium, the epithelial layer lining the urinary bladder, ureters, and kidney pelvis. Chronic pharmacological activation of PPARαis invariably associated with cancer in rats and mice. Chronic pharmacological activation of PPARγcan in some cases also cause cancer in rats and mice. Urothelial cells coexpress PPARαas well as PPARγ, making it plausible that the urothelial carcinogenicity of PPARα+γagonists may be caused by receptor-mediated effects (exaggerated pharmacology). Based on previously published mode of action data for the PPARα+γagonist ragaglitazar, and the available literature about the role of PPARαandγin rodent carcinogenesis, we propose a mode of action hypothesis for the carcinogenic effect of PPARα+γagonists in the rat urothelium, which combines receptor-mediated and off-target cytotoxic effects. The proposed mode of action hypothesis is being explored in our laboratories, towards understanding the human relevance of the rat cancer findings, and developing rapid in vitro or short-term in vivo screening approaches to faciliate development of new dual-acting PPAR agonist compounds.


2002 ◽  
Vol 42 (2) ◽  
pp. 211-216 ◽  
Author(s):  
Kazushi Okazaki ◽  
Megumi Yamagishi ◽  
Hwa-Young Son ◽  
Takayoshi Imazawa ◽  
Fumio Furukawa ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document